Showing results (2361-2370 of 5,486) with videos related to

Sort By:
Pageof 549
Pharmacotherapy|January 1, 1987
Molsidomine: alternative approaches to treat myocardial ischemiaR E Nitz, V B Fiedler
Pharmacotherapy|November 1, 1985
Amiodarone: pharmacology and antiarrhythmic and adverse effectsG V Naccarelli, R L Rinkenberger, A H Dougherty, et al.
Pharmacotherapy|January 1, 1988
A review of lithium dosing methodsF Lobeck
Pharmacotherapy|June 6, 2022
Reduced risk of NSAID-Induced adverse events with concomitant use of misoprostol (MICRO study)Mark A Munger, Scott D Nelson, Chia-Chen Teng, et al.
Pharmacotherapy|June 6, 2022
Safety and effectiveness of NMDA receptor antagonists for depression: A multidisciplinary reviewThomas J Moore, Abdallah Alami, G Caleb Alexander, et al.
Pharmacotherapy|May 24, 2022
Leveraging physiologically based pharmacokinetic modeling to optimize dosing for lopinavir/ritonavir with rifampin in pediatric patientsSara N Salerno, Edmund V Capparelli, Helen McIlleron, et al.
Pharmacotherapy|June 11, 2022
Poor tolerability of cystic fibrosis transmembrane conductance regulator modulator therapy in lung transplant recipientsChristina Teeter Doligalski, Cameron J McKinzie, Anita Yang, et al.
Pharmacotherapy|January 8, 2021
Cisplatin-induced nephrotoxicity in an outpatient settingCarly V Burns, Stephanie B Edwin, Susan Szpunar, et al.
Pharmacotherapy|June 3, 2021
NONMEM population pharmacokinetics and Monte Carlo dosing simulations of imipenem in critically ill patients with life-threatening severe infections during support with or without extracorporeal membrane oxygenation in an intensive care unitSutep Jaruratanasirikul, Apinya Boonpeng, Monchana Nawakitrangsan, et al.
Pharmacotherapy|January 6, 2021
Pharmacotherapy considerations in transgender individuals living with human immunodeficiency virusMelissa E Badowski, Nicholas Britt, Emily C Huesgen, et al.
Pageof 549